NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Overview Fund Activity
Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

29 hedge funds and large institutions have $159K invested in NKGen Biotech, Inc. Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K

Top Buyers

1
CAC
1
Cowen and Company
New York
$6.2K
2
SFA
2
Sequoia Financial Advisors
Ohio
$3.19K
3
BOCH
3
Blue Owl Capital Holdings
New York
$2.1K
4
Citadel Advisors
4
Citadel Advisors
Florida
$1.95K
5
UBS Group
5
UBS Group
Switzerland
$1.03K

Top Sellers

1
KL
1
KIM LLC
Kansas
$0
2
EAM
2
Exos Asset Management
New York
$6.25K
3
PC
3
Periscope Capital
Ontario, Canada
$0
4
FTUS
4
Flow Traders U.S.
New York
$1K
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$11.3K
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$1.03K 14,538 +932 +7%
FTUS
27
Flow Traders U.S.
New York
$1K 12,343 -2,903 -19%
CL
28
CSS LLC
Illinois
$905 12,795 – –
CCM
29
CAAS Capital Management
New York
$707 10,000 – –
KL
30
KIM LLC
Kansas
– – -92,040 Closed
PC
31
Periscope Capital
Ontario, Canada
– – -19,110 Closed
Millennium Management
32
Millennium Management
New York
– – – –
CFGS
33
Concourse Financial Group Securities
Alabama
– – – –
1
2